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Transition metal ions, especially iron, appear to bc important mediators ofoxidativc damage in vivo. Iron(H) reacts with Hz& to give more-reactive 
radicals. On the basis of ESR spintrapping data with DMPO, supported by aromatic hydroxylation studies and patterns of DNA base modification, 
it is concluded that hydroxyl radical (OH’) is likely to bc the major damaging species formed in Fenton Systems under biologically-relevant 
conditions (which include iron conccntrationp_ no higher rhan the micromolor ange). Although reactive oxo-iron species (such as ferry1 and 
perferryl) may also be important, direct chemical evidence for their formation and identity in biologically relevant Fenton systems i  currently 
lacking. Studies at alkaline pH valu~ow that iron and iron(V) species arc highly oxidizing under those reaction conditions, with a pattern 
of reactivity different from that of OH’. 
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1. HY DROXY L RADICAL EXISTS 
Hydroxyl radical’, OH’, is produced when water is 
exposed to ionizing radiation and its properties have 
been well documented by radiation chemists (e.g. [l]), 
Hydroxyl radical reacts at, or close to, a diffusion-con- 
trolled rate with almost all biological molecules. Hence 
any OH’ formed in vivo will react with whatever is 
present at its site of formation, which makes it difficult 
to trap OH’ and demonstrate its formation directly in 
biological systems [2]. Attack of OH’ upon DNA pro- 
duces a multiplicity of different products (1,3,4]; for 
example, all four purine and pyrimidine bases are mod- 
ified [4,5]. By contrast, other oxygen-derived species 
either do not react with DNA at all (examples being 
superoxide radical, Osml and hydrogen peroxide) or they 
preferentially or exclusively attack guaninc (such as 
singlet OZ and peroxyl radicals) [S]. The existence of 
repair systems which recognize many of these DNA- 
Abbreviations: DMPO, 5,5-dimethyl-I-pyrrolinc+oxide; DETA- 
PAC, diethyienctriamincpcntaacctic a id. 
‘Mydroxyl radical is often writtcn’ol-I, lo emphasize that the unpaired 
elcelron is located in the oxygen atom. 
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base lesions [6] and the excretion of a wide range of 
oxidatively-modified DNA bases in human urine [7,83 
provide good evidence consistent with the view that 
OH’ is produced in vivo and attacks DNA (and presum- 
ably other molecules as well). Of course, such data do 
not explain how the OH’ arises: some may be generated 
by background radiation. 
2. SUPEROXIDE AND HYDROGEN PEROXIDE 
As a result of the pioneering work of Chance et al. [9], 
Fridovich et al. [IO] and others (reviewed in [2]), it has 
become well established that superoxide radical (Oy-) 
and hydrogen peroxide (H,OJ are produced in vivo, 
although the exact amount of these species produced in 
mammals is still uncertain. Their generation can be ac- 
cidental (e.g. production of O;- by ‘leakage’ of electrons 
from electron transport chains [lo]) or purposeful (e.g. 
O;- production by activated phagocytic ells [l l] and 
possibly by some other cell types, such as lymphocytes 
[12], endothelial cells [13] and fibroblasts [14]). Experi- 
mental manipulations of antioxidant defence enzymes 
have shown clearly that removal of most O;- and H201 
is essential in vivo [ 10,15]. These enzymes act as a coor- 
dinated system: hence, for example, too much superox- 
ide dismutase can be deleterious [ 161. Antioxidant de- 
fences eem to be approximately in balance with gener- 
ation of oxygen-derived species in vivo. There seems to 
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be no great reserve of antioxidant dcfence (although 
defences can often be induced in response to increased 
oxidative stress [10,l 7])9 perhaps because some oxygen- 
derived species are useful [3,12-14,181. 
Why is it biologically necessary to remove most O;- 
and H202? Superoxide is a poorly reactive species [19]. 
A few metabolically-important enzymes can apparently 
be inactivated by Ol- in 
O;- H201 OH’ OH- O? 
Most has focused iron a 
but in is [28]. 
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duced reaction reduced ions H,Oz, 
in case iron the Fenton 
Fe’+ Hz02 Fe I- I- (5) 
there been controversy to 
OH’ formed all Fenton at 
pH Challenges the of 
stem erupt few and subside, 
us the [28-361. authors 
that h in systems, that 
reactive presumably complexes, 
be as although remain be 
ized [28,32]. we any spe- 
that exist additional OH’, alternatives 
it 
Before criteria demonstrating for- 
of in relevant systems, 
us whar known the of 
complexes might formed simple 
ton This not long: there 
a of literature oxo-iron 
at active of enzymes 
proteins, nothing is about 
species as (iron and 
(iron can exist simple solutions 
iron at pH. highly 
spected have the of 
tive species alternatives OH’ Fenton 
on mere of in or 
of end from 
added Fenton without any 
(e.g. NMR, evidence the 
of species. [32], et [33], 
authors Yamazaki Piette and et 
[35] emphasized dangers misinterpretation 
such Iron react only H202, 
also the products attack OH’ 
organic For Fe(IlI) react 
cr-alcohol formed attack OH’ aIco- 
Claims some that ‘oxidizing 
formed Fenton reacts slowly terr- 
butanol (Zmethylpropan -2-01) to be OH’ might be ac- 
counted for by reduction of the ‘CH,C(CHJ20H radi- 
cal by Fe(I1) [32,35]. 
Fortunately, Bielski et al. 136,371 are beginning to 
establish the precise chemistry of oxo-ion species. They 
start with a well-defined inorganic iron compound, po- 
tassium ferrate (K,FeO,), which contains Fe(V1). Solu- 
tions of this are stable for several hours at pH values 
above 8-9. One-electron reduction of fe:rate(V!) yields 
an Fe(V) species, ferratc(V). Fe (1V) can be generated 
by oxidation of Fe(II!) or, perhaps, by one-electron 
reduction of Fe(V). Fe(IV), and especially Fe(V), were 
found to be much more reactive in aqueous olution 
than is Fe(V1). For example, Fe(V) reacts with formate 
IO5 times faster than Fe(VI), lo-100 times faster with 
ascorbate [36] and 103-lo5 times faster with amino acids 
[37]. These hypervalent iron species apparently prefer to 
react with most amino acids at either the a-carbon or 
the a-nitrogen, whereas OH’ tends to react with all sites 
indiscriminately. Indeed, in the case of aromatic amino 
acids, reaction of OH” with the benzene ring is often the 
preferred reaction pathway [32,3S] whereas Fe(V) pref- 
erentially attacks the side chain. Of course, one must be 
109 
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wary of comparing the reactivity of oxo-iron species at 
highly alkaline pH values with those of OH’ at pH 7.4. 
Bearing in mind that they are conducted at highly 
alkaline pH values, the studies of Bielski et al. [36,37] 
are important because they provide guidelines as to the 
possible reactivity of any oxo-iron complexes that are 
generated in Fenton systems at pH 7.4. They also sug- 
gest methods by which Fe(V) and Fe(N) might be dis- 
tinguished from OH’ (e.g. by examining the pattern of 
products formed from aromatic ring structures). For 
example, if the reactivity of ferrate(V) at alkaline pH 
were representative of the proposed perferryl species at 
physiological pH, then assumptions [28] that perferryl 
is a fairly unreactive agent (based on the low reactivity 
of the perferryl forms of enzymes uch as horseradish 
peroxidase) may have been in error. Of course, compar- 
ison of these ferrate(V) and ferrate(IV) species with fer- 
ryllperferryl in enzymes must consider not only the dif- 
ferent pH values employed but also the great chemical 
differences between a metalloprotein with nitrogenous 
and other ligands to the metal and a simple inorganic 
oxo-iron compound. 
4. APPROACHES AND ASSUMPTIONS IN 
DEMONSTRATING HYDROXYL RADICAL 
IN FENTON SYSTEMS 
In order to demonstrate unequivocally that OH’ is 
produced in Fenton reactions, what is needed is a 
method that detects OH’ and nothing else. Many au- 
thors believe that spin trapping is such a definitive 
method [33,35,39--41], especially when DMPO is used 
as a trap, with appropriate controls to rule out artefacts 
due to the reaction of DMPO with OS-. Thus, Yamnzaki 
and Piette [39] state that ‘there is no doubt that the ESR 
spin-trapping technique is the most direct method to 
measure OH”. Determination of the pattern of end 
products of attack of reactive species upon aromatic 
compounds may also be useful for detecting OH’ [38]. 
However, the isomeric distribution of end products is 
markedly affected by the composition of the reaction 
mixture [32,38] and singlet oxygen can hydroxylate aro- 
matic rings, although it appears to give a more restricted 
range of products than does OH’ [42]. The pattern of 
chemical modification of purine and pyrimidine bases 
when DNA is exposed to Fenton systems has also been 
proposed to be diagnostic for formation of OH’ [S], 
although at least one of these products, S-hydroxygua- 
nine, can be generated by attack of other species upon 
guanine (reviewed in [S]). 
Yamazaki and Piette [39] used spin trapping with 
DMPO to study the reactions of Fe?+-DETAPAC, 
Fe2+- EDTA and Fe’+-ADP with H20z at pH 7.4. They 
concluded that, at low (cl PM) Fe?’ concentrations, 
OH’ was formed almost quantatively according to equa- 
tion 5. At higher Fe”+-EDTA or Fe’+-ADP concen- 
trations, the stoichiometry changed and the results were 
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explained on the basis of formation of both OH’ and of 
additional oxidizing species (although, again, no direct 
evidence for existence of these species was presented). 
If we accept he spin-trapping data [33-35, 39-411, it
is clear that OH’ k formed in Fenton reactions at pH 
7.4, a result supported by aromatic hydroxylation stud- 
ies [38] and patterns of DNA base modification [S]. 
However, it must be noted that there is no direct proof 
that DMPO reacts only with OH’. For example, it 
might react with ferry], 
Fe(IV)=O+-DMPO+H’+Fe(lII)+DMPO-OH (6) 
and/or with other oxo-iron species. Indeed, the DMPO- 
OH adduct may be produced by reaction of the spin 
trap with hypochlorous acid or singlet O? [66,G7], so it 
is clearly not specific for Ow. Similarly, ferry1 and/or 
perferryl ssies might be able to hydroxylate aromatic 
compounds and oxidize DNA bases, although the 
DNA-cleaving blcomycin-oxo-iron species (thought to 
be a perferryl or ferry1 bleomycin [43]) does not form 
DNA base oxidation products of the type that OH’ can 
generate [443. Oxo-iron species might also be able to 
react with some or all of the commonly used OH’ scav- 
engers, but there is considerable disagreement on this 
point between the papers postulating such species. For 
example, some studies claim that ‘non-OH’ species’ gen- 
erated in Fenton reactions do not react with tert-bu- 
tanol [29,45] whereas others claim that they do [34]. 
Apart from this fundamental question as to what is 
measured, there are several other concerns in applying 
spin-trapping techniques to biological Fenton systems 
[40]. Many of the reducing agents that recycle Fe(H) 
interfere with the spin-radical adduct. Thus, ascorbate 
can reduce it to an ESR-silent species and so, ascorbate 
may appear to be an antioxidant when it is actually 
accelerating OH’ formation (Gutteridge and McCay, 
unpublished ata). Another consideration is that spin 
traps may have to compete with biological molecules for 
binding the iron needed to drive site-specific biological 
Fenton chemistry. Indeed, the design of spin traps with 
metal-binding ability is an interesting approach for the 
future. 
In the view of the authors, progress will only be made 
when the oxo-iron species are characterized chemically 
and their reactions with DMPO, aromatic compounds 
and DNA are studied irectly9 and compared with those 
of OH’, The existence of oxo-iron species cannot be 
established on the basis of anomalies in reaction kinetics 
or in formation of end products. The pioneering studies 
of Bielski et al. [36,37] need to be extended to biologi- 
cally relevant conditions. 
5. MOW MUCH FENTON-REACTIVE IRON EX- 
ISTS IN VIVO? 
If we accept the spin-trapping data at face value, it 
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seems that OH’ is the major, if not the only, reactive 
species formed in Fenton chemistry at low Fe concen- 
trations [33-351 although t,he ligand to the iron and the 
Hz02 concentration are also important variables 
[28,29,31,33,35,46]. How much ‘catalytic’ iron actually 
exists in vivo? 
Organisms take great care in the handling of iron, 
using transport proteins uch as transferrin and storage 
proteins such as ferritin and haemosiderin to minimize 
iron reactivity and availability (reviewed in [18,47]). 
Thus, for example, plasma from healthy human adults 
contains no ‘free’ iron capable of promoting Fenton 
chemistry (reviewed in [48]). The effectiveness of this 
iron ion sequestration may be illustrated not only by 
biochemical analysis [18,47,48], but also by a simple 
observation. Humans appear to be able to consume 
large quantities of ascorbic acid for years without ill 
effects. Indeed, ascorbate may have important antioxi- 
dant properties in vivo in healthy subjects [49]. Yet, in 
the presence of iron and copper ions, ascorbic acid ac- 
celerates oxidative damage towards DNA, lipids and 
proteins [2,5,18,28,50]. It follows that catalytic metal 
ions are available only to a very limited extent in vivo: 
indeed, safe ‘sequestration’ of transition metal ions is 
probably an important antioxidant defence in its own 
right [2,18,28,47], aswell as allowing ascorbate to exert 
its antioxidant effects. In agreement with this conclu- 
sion, giving ascorbate to iron-overloaded patients who 
have non-transferrin-bound iron in their plasma can be 
deleterious [S I]. 
This limited availability of transition metal catalysts 
of Fenton chemistry in vivo is supported by results 
obtained using the bleomycin assay, developed by Gut- 
teridge et al. as a first attempt o measure the availabil- 
ity of iron complexes catalytic for free radical reactions 
in human body fluids (reviewed in [48]). Except in the 
special case of iron overload, iron concenirations meas- 
ured in body fluids by the bleomycin assay are rarely 
greater than l-2 ,uM, often less, and are zero in plasma 
from healthy humans [48]. Intracellular iron levels arc 
uncertain, but may be in the same low range. 
Thus, if ‘catalytic: iron levels are very low in vivo, 
Ihen any biologically relevant Fenton chemistry will 
operate under conditions that are reported to favour the 
formation of OH’ [34,39]. Levels of ‘catalytic’ copper 
are not well established, but the limited data available 
suggest hat they are even lower than those of iron in 
humans [52,53]. Thus, as has been emphasized previ- 
ously [2,18], experiments in vitro in which 50-200 ,uM 
concentrations of iron complexes are used to stimulate 
lipid peroxidation or OH’ generation are unrepresenta- 
tive of the situation in viva. That iron-dependent free 
radical reactions do nevertheless, occur in vivo and are 
important mediators of oxidative damage is supported 
by a wealth of evidence, as has been discussed by differ- 
ent scientists many times in the past decade (e.g. see 
[2,5,18,27,28,41,43,47,54-65]). 
nc~/runk~~~~rrl~ellrs: The aulhors arc very grateful to Dr. Ben Bielski 
for his helpful comments and criticisms. Barry Halliwcll thanks the 
Arthritis and Rhcumal.ism Council, Cancer Rcscarch Campaign and 
Medical Research Council ror support. J.M.C.G. thanks the British 
Lung Foundation for support. 
REFERENCES 
[I] Von Sonnlag, C. (1987) The Chemical Basis of Radiation Biol- 
oby, Taylor and Francis, London. 
[2] Halliwcll, B. and Guttcridgc. J.M.C. (1989) Free Radicals in 
Biology and Medicine, Sceond Edition, Clarcndon Press. Oxford. 
[3] Sucnkcn. S. (1989) Chcm. Rcs. 89. 503-520. 
[4] Dirdaroglu. M. (1990) Methods Enzymol. 193, 841-857. 
[5] Halliwcll. B. and Aruoma. 0.1. (1991) FEBS Let,. 251. 9-19. 
[6] Brcimcr. L.H. (1991) Free Radial Rcs. Commun. 14, 159-171. 
[7] Wuyncr. J.R.. HU, C.C. and Ames, B.N. (1992) Proc. Natl. Acad. 
Sci. USA 89, 3380-3384. 
[8] Stillwcll. W.G., Xu, H.X.. Adkins, J.A.. Wishnock, J.S. andTan- 
ncnbaum. S.R. (1989) Chcm. Rcs. Tox. 2.94-99. 
[9] Chance. B.. Sits, H. and Bovcris. A. (1979) Physiol. Rev. 59. 
527-60s. 
[IO] Fridovich. 1. (1989) J. Biol. Chcm. 264, 7761-7764. 
[I I] Babior, l3.M. und Woodman, R.C. (1990) Scmin. Hematol. 27. 
247-259. 
[12] Maly. F.E. (1990) Free Radical Rcs. Commun. 8, 143-148. 
[I31 Babbs. C.F.. Crcgor, M.D..Turck. J.J.and Badylak.S.F.(199lj 
Lab. Invest. 65. 484+9G. 
[I41 Murrcll. G.A.C.. Francis. M.J.O. and Bromlcy. L. (1990) Bio- 
chcm. J. 265. 659-(165. 
[IS] Touuli, D. (1989) Free Radical Rcs. Commun. 8. l-8. 
[I61 Amst;id. P.. Pcskin, A.. Shah, G.. Minult, ME.. Morel, R.. 
Zbindcn, 1. and Ccrutti, P. (1991) Biochemistry 30. 9305-9313. 
[I71 Turtapli;l. L.A.. Gimcnos, C.J., Storz, G. and Ames. B.N. (1992) 
J. Biol. Chcm. 2G7, 2038~2045. 
[18] Halliwcll, 13. and Guttcridgc, J.M.C. (1986) Arch. Biochcm. Bio- 
phys. 146. 501-514. 
[I91 Biclski. B.H.J. and Cabclli, D.E. (1991) Int. J. Radiat. Biol. 59. 
291-319. 
[20] Gardner, P.R. and Fridovich. I. (1991) J. Biol. Chem. 266,19328- 
19333. 
[31] Funburg, B.L.. Massaro, D.J., Ccrttnti, P.A.. Gail, D.B. and 
Burbcrich. M.A. (19921 Am. J. Phvsiol. 262. L235-L24l. 
[22] Bcauchamp, C. ind Fridovich, 1: (1970) J. Biol. Chcm, 245, 
46413646. 
[33] Beckman. J.S.. Beckman, T.W.. Chcn. J., Marshall, P.A, and 
Freeman, B.A. (1990) Proc. Natl. Acad. Sci. IJSA87.1620-1624. 
[24] Ilog& H.. Darlcy-Usmnr. V.M.. Wilson, M.T. and Moncada, S. 
(1992) Diochcm. J. ?81,419~24. 
[25] Kannur, I.. Harcl, S. and Granit, R. (1991) Arch. Bioehem. Bio- 
phys. 289, 130-l 36. 
[26] Rubanvi. G.M.. Ho. E.H.. Cantor. E.H.. Lumma. WC. and 
Botclh~,‘L.H.P.‘(19~l) Biochcm. Bibphys: Rcs. Commun, 181, 
1392-l 397. 
Halliwell, B. (1989) Free Radical Rcs. Ccmmun. 5. 315-318. 
Halliwell, B. and Guttcridgc. J M.C. (1990) Methods Enzymol. 
186. l-85. 
Rush, J.D. and Koppcnol, W.H. (1986) J. Biol. Chem. 261.6730- 
6733. 
Maskos. 2. and Koppenol. W.H. (1991) Free Rad. Biol. Med. I I, 
609-610. 
Guttcridgc, J.M.C.. Maid,, L. and Payer. L. (1990) Biochcm. J
269, 169-I 74. 
Wa!ling. C. (1975). Act. Chem. Rcs. 8. 125-132. 
Fitchctt, M.. Gilbert, B.C. and Jeff, M. (1985) Phil. Tnns R. See. 
Lond. B3l I. 517-529. 
Yamazaki. I. and Phtc, L.H. (1991) J. Am. Chcm. Sot. 113. 
7588-759. 
Volun~c 307, number 1 FEBS LETTERS July 1992 
[35] Croft. S.. Gilbert, B.C.. Lindsay Smith, J.R. und Whitwood, AC. 
(lY92) Free Radical Res. Commun, in the press. 
[36] Biclski. B.H.J. (1991) Free Radical Res. Commun. 12, 469477. 
[37] Sharma, V.K. and Bielski, B.H.J. (1991) Inorg. Chem. 30,4306- 
4310. 
[38] Halliwell. B.. Gu:teridge, J.M.C. and Graotveld, M. (1988) 
Methods Biochem. Anal. 33, 59-90. 
[39] Yamazaki, 1. and Piettc, L.H. (i990) J. Biol. Chem. 265. 13589- 
13594. 
[40] Finkelstein, E., Rosen, GM. and Rauckman. E.J. (1980) Arch. 
Biochem. Biophys. 200. I-16. 
[4l] Burkitt, M.J. and Mason. R.P. (1991) Proc. Natl. Acad. Sci. USA 
88,544@5444. 
[42] Feix, J,D. and Kalyanaraman, B. (1991) Arch. Biochem. Bio- 
phys. 291, 43-S I, 
[43] Petering, D.H., Bymes, R.W. and Antholine, W.E. (1990) Chcm.- 
Biol. Interac. 73, 133-182. 
[44] Gajewski. E.. Aruoma. O.I., Dizdaroglu, M. and Halliwcll, B. 
(1991) Biochemistry 30. 2444-244s. 
[45] Rahhal, S. and Richter, H.W. (1988) J. Am. Chcm. Sot. 110. 
31263133. 
[46] Guttcridge, J.M.C.. Zs-Nagy, 1.. Maidt. L. and Floyd, R.A. 
( 1990) Arch. Biochcm, Biophys. 277, 422-428. 
[47] Halliwell. B. and Guttcridge, J.M.C. (1990) Arch. Biochem. Bio. 
phys. 280, l-8. 
[48] Gutteridge, J.M.C. and Halliwcll, B, (1987) Life Chem. Rep. 4, 
113-142. 
[49] Stocker. R. and Frci, B. (1991) In Oxidativc Stress, Oxidantsand 
Antioxidants (I-i. Sits, Ed.), Academic Press, New York. 
[50] Stadtman, E.R. and Oliver, C.N. (1.991) J. Biol. Chem. 266,2005- 
2008. 
[5l] Nienhuis, A.W. (1981) New Engl. J, Med. 304, 170-171. 
[52) Gutteridge, J.M.C. (1984) Biochem. J. 218,983-9&X 
[53] Evans, P.J., Bornford, A. and Halliwcll, B. (1989) Free Radical 
Res. Commun. 7, 55-62. 
[54] Aust, SD.. Morehouse, L.A. and Thomas, C.E. (1985) Adv. Free 
Rad. Biol. Med. I, 3-25. 
[55] Cochrane, C.G. (1991) Mol. Aspects Med. 12, 137-147, 
[56] Imlay, J.A. and Linn, S. (1988) Science 240, 1302-1309. 
[57] Wolff, S.P. (1987) in Diabetic Complications (M.J.C. Crabbe, 
Ed.), Churchill Livingstone, Edinburgh. 
[58] Farber, J.L, (1990) Chrm. Res. Tox. 3, 503-508. 
[59] Ferrali, M., Ciccoli, L., Signorini, C. and Comporti, M. (1990) 
Biochem. Pharmacol, 40, 1485-1490. 
[GO] Britigan, BE. and Edeker, B,L. (1991) J. Clin. Invest. 88, lO92- 
1102. 
[6l] Walker, P.D. and Shah, S,V, (1991) Kidney Int. 40, 891-898. 
[6?] Frank, L. (1991) Free Rad. Biol. Med. 1 I, 341-348. 
[63] Mello-Filho, A.C. and Meneghini, R. (1991) Mtn. Res. 251, lO9- 
113. 
[64] Bissett, D,L., Chatterjee, R. and Harmon, D.P. (1991) Photo- 
them. Plrotobiol. 54, 215-223. 
1651 Howard, R.L., Buddington, B, and Allfrey, AC. (1991) Kidney 
Int. 40, 923-926. 
[6GJ Sai. K., Uchiyama, S., Ohno, Y., Hasegawa, R. and Kurokawa, 
Y. (1992) Carcinogenesis 13.333-333. 
[67] Bernofsky, C., Bandara, B.M.R. and Hingosa, 0. (1990) Free 
Rud. Biol. Med. 8, 231-239. 
112 
